Diagnosis and risk stratification of PI-RADS v2.1 category 3–5 lesions using amide proton transfer imaging - Quiz - MDSpire

Diagnosis and risk stratification of PI-RADS v2.1 category 3–5 lesions using amide proton transfer imaging

  • By

  • Hongkun Fang

  • Weishu Hou

  • Qun Wang

  • Xiaoyu Zhang

  • Xiao Wang

  • Shuhai Zhang

  • Shoubin Li

  • Xiaohu Li

  • Yongqiang Yu

  • May 6, 2025

  • 0 min

Share

Original Source(s)

Diagnosis and risk stratification of PI-RADS v2.1 category 3–5 lesions using amide proton transfer imaging

  • by Hongkun Fang, Weishu Hou, Qun Wang, Xiaoyu Zhang, Xiao Wang, Shuhai Zhang, Shoubin Li, Xiaohu Li, Yongqiang Yu

  • May 6, 2025

Related Content

Unveiling the challenges of UTUC biopsies and cytology: insights from a global real-world practice study

Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?

Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA